Cronos Group reported a net revenue of $11.4 million, a gross loss of $1.5 million, and an operating loss of $41.2 million for Q3 2020. The company saw revenue growth primarily driven by the Canadian cannabis market, the Redwood acquisition, and the Israeli medical cannabis market.
Net revenue of $11.4 million in Q3 2020 increased by $5.6 million from Q3 2019.
Gross loss of $1.5 million in Q3 2020 decreased by $1.6 million from Q3 2019.
Reported operating loss of $41.2 million in Q3 2020 increased by $10.5 million from Q3 2019.
Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman
No specific forward guidance provided in the earnings report.
Visualization of income flow from segment revenue to net income